Search

New patient education infographic from Cl-ear™

According to research into the nation’s hearing health habits commissioned by Cl-ear™, the fastest growing OTC ear care range¹, DIY ear wax removal is rife.

Leading in cochlear implant reliability

All MED-EL’S titanium cochlear implants since 2006 have an overall cumulative survival rate of over 99%.

Develop your clinical skills with the Interacoustics Academy

The Interacoustics Academy supports hearing care professionals by giving access to the most current and relevant clinical knowledge in hearing and balance.

Clinical Observations of Otinova in everyday life

Otinova for Otitis Externa or ‘swimmers ear’. When Associate Professor and senior physician Mats Engstrom came across Otinova in his ENT clinic in Lakarhuset, Uppsala, he collected detailed information about the patients who tried the preparation.

Export data directly to Noah from OtoAccess® Database

Together with OtoAccess®, Interacoustics is happy to introduce a new updated version of their popular OtoAccess® Database.

Otovent new app launched – come and explore Otopia!

Otovent proudly launches their new fun, easy to use app to help track Otovent use.

MED-EL revolutionises cochlear implantation with unparalleled synchrotron dataset of temporal bones

MED-EL, a leading innovator in the field of cochlear implant research and development, has announced an agreement with the Western University (London, Canada) and Mitacs to gain exclusive access to an extraordinary synchrotron dataset of temporal bones.

BHM-Tech takes over the Sophono product line from Medtronic

We are pleased to announce, that we have taken over the global support of the Sophono hearing system from owner Medtronic.

Peptest Q&A

Untreated reflux can cause inflammation, scarring, narrowing and precancerous changes in the oesophagus and larynx, and may increase the risk of asthma and sleep apnoea.

Neuromod Devices’ €30m funding powers Lenire expansion

Neuromod Devices, the global technology business behind scientifically proven tinnitus treatment technology, Lenire, closed €30m funding to expand availability of the groundbreaking tinnitus intervention.

Get 20% off your ticket to the Tinnitus Conference 2023

Join Tinnitus UK for their fourth virtual Tinnitus Conference with 20 sessions presenting the latest information and research from world leaders at the forefront of tinnitus and tinnitus support.

Interacoustics introduces a new diagnostic test at EUHA

Interacoustics is happy to introduce the Audible Contrast Threshold (ACT™) test; a new, diagnostic test to support the number one challenge with hearing loss: difficulty hearing speech in background noise.